
1. Technology overview
DeepTrace Technologies SRL is an Italian company, founded in June 2018 and headquartered in Milan, that builds artificial intelligence software for medical image analysis. It was recognised as the first spin-off of IUSS Pavia and targets earlier and more consistent diagnosis from MRI, ultrasound, CT and mammography.
The TRACE4 portfolio includes CE-cleared software as a medical device: TRACE4AD estimates 24-month dementia risk from brain MRI, TRACE4BUS assigns a BI-RADS category to breast ultrasound, and TRACE4OC estimates ovarian cancer risk from ultrasound. Trace4Research, Trace4DigitalTwin and Trace4Telemed add research analytics, patient digital twins and remote consultation. The company reports over 140 sites using the technology in more than 10 countries.
2. Highlighted features & specifications
- TRACE4AD: estimates 24-month dementia risk from brain MRI.
- TRACE4BUS: analyses breast ultrasound and gives a BI-RADS category.
- TRACE4OC: estimates ovarian cancer risk from ultrasound images.
- Trace4Research: image-analytics platform for researchers without coding skills.
- Trace4DigitalTwin: combines patient health data with population data for planning.
- Trace4Telemed: supports remote patient-physician consultation and monitoring.
3. Potential application
A provincial hospital in Vietnam could use TRACE4BUS to support breast ultrasound reading in screening programmes. A university hospital could use Trace4Research for imaging studies on neurodegeneration. A private imaging chain could pilot AI risk scoring integrated with its PACS.
4. Benefits
Supports radiologists with risk scores and BI-RADS categories from routine images. Uses CE-cleared software, easing adoption in regulated hospital settings. Covers several modalities and diseases in one vendor portfolio. Includes research and remote-consultation modules for academic and clinical sites.
5. Market trends & opportunities
Radiology workloads keep growing while specialists remain scarce, so hospitals look for AI that triages and quantifies images. Population screening for breast cancer and dementia risk is expanding, and Vietnamese hospitals are building PACS and digital imaging capacity that could host such tools.
6. Other information
Founded June 2018, headquartered at Via Conservatorio 17, Milan, Italy. First spin-off of IUSS Pavia (2020). Closed a PoC and seed round with Progress Tech Transfer fund and partnered with EBIT (Esaote Group). Exhibited at ECR and ARM events.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































